Norges Bank’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-25,000
| Closed | -$311K | – | 2217 |
|
2021
Q4 | $311K | Sell |
25,000
-197,400
| -89% | -$2.46M | ﹤0.01% | 2171 |
|
2021
Q3 | $6.95M | Buy |
222,400
+197,400
| +790% | +$6.17M | ﹤0.01% | 1856 |
|
2021
Q2 | $716K | Hold |
25,000
| – | – | ﹤0.01% | 2140 |
|
2021
Q1 | $1.08M | Buy |
25,000
+5,000
| +25% | +$217K | ﹤0.01% | 2043 |
|
2020
Q4 | $1.43M | Hold |
20,000
| – | – | ﹤0.01% | 1989 |
|
2020
Q3 | $603K | Buy |
+20,000
| New | +$603K | ﹤0.01% | 2069 |
|